
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Herbal supplements and other complementary therapies are surrounded by clinical and ethical issues, some involving urologists.





